Source:http://linkedlifedata.com/resource/pubmed/id/18083294
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2008-11-5
|
| pubmed:abstractText |
The Epstein criteria represent the most widely used scheme for prediction of clinically insignificant prostate cancer (PCa). However, they were never validated in European men. We assessed the rate of unfavorable prostate cancer (Gleason 7-10 or non-organ-confined disease) in a cohort of 366 men who fulfilled the Epstein clinically insignificant PCa criteria.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0302-2838
|
| pubmed:author |
pubmed-author:AhyaiSaschaS,
pubmed-author:ErbersdoblerAndreasA,
pubmed-author:GraefenMarkusM,
pubmed-author:HaeseAlexanderA,
pubmed-author:HeinzerHansH,
pubmed-author:HulandHartwigH,
pubmed-author:HuttererGeorg CGC,
pubmed-author:JeldresClaudioC,
pubmed-author:KarakiewiczPierre IPI,
pubmed-author:LattoufJean-BaptisteJB,
pubmed-author:SuardiNazarenoN,
pubmed-author:WalzJochenJ
|
| pubmed:issnType |
Print
|
| pubmed:volume |
54
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1306-13
|
| pubmed:meshHeading | |
| pubmed:year |
2008
|
| pubmed:articleTitle |
Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.
|
| pubmed:affiliation |
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Validation Studies
|